insights_auto
Why is 3696 down 4.63%?
Dive Deeperchevron_right
3696:HKG
Insilico Medicine Cayman TopCo
HK$41.60
arrow_downward
-4.63%(-2.02) 1D
Oct 14, 4:08:24 PM GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 3696...
Open
HK$43.14
High
HK$43.40
Low
HK$41.22
Mkt. cap
24.34B
Avg. vol.
15.33M
Volume
10.77M
52-wk high
HK$80.90
52-wk low
HK$29.98
EPS
-HK$4.20
Shares outstanding
557.42M
No. of employees
333
Open
HK$43.14
High
HK$43.40
Low
HK$41.22
Mkt. cap
24.34B
Avg. vol.
15.33M
Volume
10.77M
52-wk high
HK$80.90
52-wk low
HK$29.98
EPS
-HK$4.20
Shares outstanding
557.42M
No. of employees
333
News stories
From web sources and news partners
TipRanks
·
1 day ago
InSilico Medicine Advances AI‑Designed Autoimmune Drug Candidate ISM9546
Profile
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company applies genomics, big data analysis, and deep learning for in silico drug discovery. Wikipedia
About Insilico Medicine Cayman TopCo
CEOFeng Ren | Alex Zhavoronkov
Employees333
Founded2014
Headquarters-
SectorHealth care
Websiteinsilico.com